S494-119

What This Bill Does

The Senate-passed National Plan for Epilepsy Act directs the Health and Human Services Secretary to review and, where appropriate, update existing federal epilepsy programs, activities, and strategic plans. The review must examine evidence-based and federally funded research, knowledge gaps, health disparities, coordination across programs, near- and long-term goals, federal investment, and opportunities to inform global work. HHS must consider ways to improve federal and stakeholder collaboration, eliminate research gaps, address effects on people with epilepsy and caregivers, improve early diagnosis and care coordination, prevent sudden unexpected death and other epilepsy mortality, strengthen surveillance, support new treatments and quality-of-life strategies, and improve public-health approaches. The Secretary must regularly convene relevant federal agencies, patient advocates, and nonfederal subject-matter experts. Within two years of enactment, HHS must report to the Senate HELP Committee and House Energy and Commerce Committee on the review, stakeholder feedback and needs, recommendations and implementation proposals, recommended federal program or strategy changes, and statutory or other barriers. The final bill is narrower than the introduced version: it does not establish a permanent National Plan project, an epilepsy advisory council, annual national assessments, or a recurring advisory report.

Who Benefits and How

People with epilepsy and their caregivers gain a formal opportunity to identify unmet needs and influence federal recommendations. Patient advocates, clinicians, epilepsy researchers, and public-health experts gain a recurring consultation role during the review. Federal health agencies and congressional committees gain a consolidated assessment of research gaps, disparities, program coordination, investment, surveillance, mortality prevention, treatment development, and implementation barriers. Research and care organizations may benefit from better aligned federal priorities.

Who Bears the Burden and How

HHS must coordinate a cross-program review, consider updates to existing plans, regularly convene agencies and outside stakeholders, synthesize evidence and feedback, and submit the detailed report within two years. Participating agencies, advocates, experts, and researchers must devote time and information to the review. Congressional health committees must evaluate recommendations and any requested statutory changes. Compared with the introduced bill, potential advisory-council members and National Plan administrators lose the proposed standing structure and annual assessment process.

Key Provisions

• Requires HHS to review federal epilepsy research, prevention, identification, diagnosis, treatment, and strategic plans.
• Requires examination of evidence, disparities, program coordination, federal investment, surveillance, mortality, and treatment gaps.
• Requires regular consultation with federal agencies, patient advocates, and nonfederal experts.
• Requires a report to congressional health committees within two years with feedback, recommendations, implementation proposals, and barriers.
• Limits the final approach by omitting the introduced permanent National Plan, advisory council, and annual assessments.